Innovation

Transgenic Mice for Testing and Screening Anti-Fibrotic Therapy

University of California System: University of California, San Diego
posted on 06/15/2011

Brief description unavailable


Innovation Details
 

Detailed Description

UC San Diego investigators have created transgenic mice that could be useful as an animal model for any type of fibrosis study. Their advantage is that any individual mouse could be assayed at any point in time without sacrificing the mouse. Also, any type of collagen Type I fibrosis could be studied in these mice, including cardiovascular, pulmonary, kidney, or cystic fibrosis. While not a high throughput system, the mice could be a secondary screening for therapeutic agents for anti-fibrotic drugs.

File Number: 21775 


IP Protection

Copyright: ©2011-2014, The Regents of the University of California

License Online

This innovation currently is not available for online licensing. Please contact University of California, San Diego Technology Transfer Office at University of California System: University of California, San Diego for more information.

Request more info via email request more info
People

Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

12,872 members 17,313 innovations 176 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...